301015 · 青岛百洋医药股份有限公司 · Financials
Market Cap
13.50B CNY
Shares
525.62M
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Browse captured authority reports and their original financial labels
No structured figures reported for this view yet.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Bonds payable | 2026-06-30 | CNY 793,107,245 | Interim report filed 2026-08-29 |
| Lease liabilities | 2026-06-30 | CNY 99,029,090 | Interim report filed 2026-08-29 |
| Long-term borrowings | 2026-06-30 | CNY 521,861,458 | Interim report filed 2026-08-29 |
| Short-term borrowings | 2026-06-30 | CNY 2,331,093,311 | Interim report filed 2026-08-29 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.